Marker Learning

Overview

The first digital-native clinical assessment, designed to evaluate students more fairly across language, culture, and background. Adaptive, examiner-light, and fair by design.

Funding and backers

Total raised
$15M
1 round on record
Latest round
$15M
Venture round · Feb 2023 · 3 yr ago
Team
51-200
employees, estimated range
Backers
2
Primary Venture Partners, Andreessen Horowitz
The money's age
Long since its last round
45 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 8, 2023 Raised a round Venture round $15M Dec 2021 Website went live first capture in the Wayback Machine
Funding rounds
RoundDateAmountInvestorsSource
Venture round Feb 2023 $15M — businesswire.com
Backed byfrom the funds' portfolios and accelerator catalogs
Primary Venture Partners fund Andreessen Horowitz fund
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Exonic, Kimpton
Antler
backs Zero Electric
General Catalyst
backs Paradigm Health
GV
backs Paradigm Health
Global Brain
backs IgGenix# Life Science/Healthcare# North America
ARCH Venture Partners
backs Paradigm Health
Similar startupsby what they do, their industry and backers
LenderSquaredConvertible Note $335k · 13 mo ago · Founded 2025
Smarter lending, squared.. One platform to evaluate risk, automate workflows, and fund faster—with clarity and control.
ClinicomVenture round $800k · 4 yr ago · Founded 2021
One adaptive assessment evaluates 80+ DSM conditions and returns a clinician-ready report. Built on patented clinical algorithms. In…
Insilica1-10 employees
About Insilica We're building the intelligence required to evaluate any substance, at any exposure, at any scale. The toxicology industry…
Paradigm HealthSeries B $78M · 11 mo ago · Founded 2017 · 201-500 employees · 10 roles
Paradigm Health is the AI-native clinical trial platform connecting biopharma sponsors with a research-ready provider network across 2,100…
KimptonFounded 2025 · 11-50 employees · 1 role
Kimpton builds private environments and benchmarks to evaluate your models. Compare task outcomes and inspect recorded decisions through…
IgGenix# Life Science/Healthcare# North America51-200 employees
Clinical Trials. A Phase 1, randomised, double-blind clinical study to evaluate the safety and tolerability of IGNX001, an injectable…

Financials

Total raised
$15M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $15M Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
Primary Venture PartnersVia a fund
49 portfolio companies: Forge Point, Lili, Lyric and 46 more
Andreessen HorowitzVia a fund
857 portfolio companies
Report a mistake

News